I. INTRODUCTION
The presence of yeasts in samples of normally sterile deep tissue or closed body cavity, such as blood, peritoneal fluid, cerebrospinal fluid and urine which gathered through catheterization or suprapubic puncture has been referred to as invasive fungal infections (IFIs). With the development of the skill of the neonatal intensive care, IFIs has become an important part of nosocomial infection in neonatal intensive care units (NICU), the morbidity of invasive fungal infection is 0.57-2.9% [1, 2] which accounts for 6.8%-12% [3] of nosocomial infection.
Preterm infants whose gestational age (GA) less than 37 weeks, especially the ELBW infant, due to their relative immunodeficiency, immature skin structure, repeated invasive procedures and the prolong use of broad-spectrum antibiotics, are at high risk of developing IFIs. There were lots of researches about IFIs in premature infant till now and founded the risk factors associated with IFIs include male, younger gestational age, low birth weight, asphyxia after birth, receipt of broad-spectrum antibiotics, Peripherally inserted central catheter (PICC), mechanical ventilation and prior steroid therapy [4] [5] [6] [7] [8] [9] [10] . In addition, the prophylaxis of fluconazole to prevent IFIs is still controversial [11] [12] [13] [14] . In the recent years, some scholars raise doubts: on one hand, the fluconazole prophylaxis may decrease the occurrences of invasive fungal infection, but have nothing to improve with the mortality; on the other hand, the knowledge about pharmacological and pharmacokinetic of fluconazole in prematurity are limited, so the dosage and the duration are not clear.
II. MATERIALS AND METHODS

A. Research Object and Method
This retrospective cohort study was conducted at the First Hospital of Jilin University, Changchun, China. The research sample population includes whose gestational age less than 37 weeks and who were hospitalized for more than two days from from January 1, 2013 to January 1, 2017. The ethical approval was received prior to conducting this study. A data collection form was made and all data were collected from the patients chart in the hospital. End point of observation was 140 days after birth, discharge or death.
B. Grouping and Outcome
All the research objects that meet the standard were divided into an exposure group and a control group according to exposure factors which were included ten suspicious high risk factors and one suspicious protective factor. Suspicious high risk factors include male, earlier premature infants whose gestational age less than 34 weeks, low birth weight infant whose birth weight less than 1500g, asphyxia after birth which were diagnosis as Apgar score less than 5 at 5 minute after delivery, PICC, mechanical ventilation, HCMV infection which were diagnosis as the major matrix phosphoprotein 65 (pp65) of cytomegalovirus positive, combination with bacterial infection which was diagnosis as positive bacterial culture of blood, cerebrospinal fluid or urine, the use of spectrum antibiotic which was diagnosis as three-generation or above cephalosporin and carbapenem antibiotic before the fungal positive training, application of glucocorticoid before the fungal positive training. Suspicious protective factor was using fluconazole for more than three days before the fungal positive culture. Outcome was invasive fungal infection which was diagnosis as fungal culture positive of blood, cerebrospinal fluid or urine for premature infants with/without onset.
C. Statistical Method
All exposure factors were calculated to see whether they were independent risk factors or protective factor for the disease through the inspection of single factor χ2 and the unconditional logistic regression of multi-factors. The data were retrospectively collected. The 11 items of the exposure factors related to the invasive fungal infection of premature infants were assigned values ( Table 1 ). The single factor χ2 test analysis was conducted, that was, the foundation of the data analysis for the preliminary screening of variables. In order to avoid information lost, the exposure factors with P<0.1 would be listed as standard, the significant variable was taken into the logistic regression equation as an independent variable. Whether each exposure factor was related to the invasive fungal infection of premature infants was clarified and the OR value and its 95% confidence interval was calculated, SPSS11.5 software was adopted for data analysis. 
III. RESULTS
A. Basic Information
Finally, 6,638 premature infants were included. Among them, 77 premature infants were diagnosis as invasive fungal infection. The characteristics of premature infants with fungal infection as table 2. For premature infants with birth weight more than 2500g, between 1500g and 2500g, between 1000g and 1500g, the morbidity was 0.85% (2 cases in 235 cases), 6 .09% (44 cases in 722 cases), 8.29% (30 cases in 164 cases) respectively. For premature infants with birth weight less than 1000g, the morbidity was 5.55% (1 case in 18 cases). It showed there were inverse relationship between the morbidity rate and the birth weights among the premature infants with birth weights more than 1000g. 
B. Short-Term Prognosis and Pathogens Distribution
The median length of the hospital stay was 13 days for premature infants without fungal infection, and that were 7 days and 22 days in 25th percentile and 75th percentile. The median length of the hospital stay was 33 (22, 47) days for premature infants with invasive fungal infection. The two were of significant difference (Table 2) . Among the invasive fungal infection cases, there were 36 cases with smooth Candida yeast (47%), 32 cases with candida albicans (41.5%), 3 cases with tropical candida yeast (4%), 2 cases with nearly smooth candida (2.5%), 2 cases with candida lusitaniae (2.5%) and 2 cases with an unknown candida yeast (2.5%), including one case in which the patients had both an unknown candida yeast infection (11 days after birth) and a smooth candida yeast infection (17 days after birth).
C. Risk Factors Analysis
The exposure factors that may be meaningful to premature infants with invasive fungal infection include: PICC, Broad-spectrum antibiotics, invasive assisted ventilation, HCMV infection, bacterial infection, young gestational age, prophylactic use of fluconazole, low birth weight, glucocorticoids application. The above factors were all of statistical significance (P<0.01). Factors that have no obvious effect on disease were excluded: Male and asphyxia after birth (Table 3) . Many exposure factors with statistical significance in the single factor analysis result were conducted by a gradual unconditional logistic regression analysis. PICC, HCMV infection, broad-spectrum antibiotics application and invasive mechanical ventilation were independent risk factor for premature infants with invasive fungal infection. They were of significant difference (Table 4) . 
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IV. DISCUSSION
The research result shows that the morbidity was different for premature infants with different birth weights, there were inverse relationship between the morbidity rate and the birth weights among the premature infants with birth weights more than 1000g. But, the morbidity rate of the extremely low birth weight infants in this study was only 5.55%, maybe because there were few infants in this group. IFIs increased the mortality of premature infants and extend the length of hospital stay.
The research finds that HCMV infection, PICC, mechanical ventilation and broad-spectrum antibiotics application are independent risk factors of premature infants with IFIs. When the body is infected by the cytomegalovirus,
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the function of thymus and spleen will be damaged. Premature infants with congenital cytomegalovirus infection are easy to merge conditioned pathogen infection which includes fungus. For premature infants who need PICC, the related infection of preventive venous catheter is more meaningful, including peripheral vascular selection, aseptic operation, and the application of small dose of heparin, the appropriate maintaining of pump speed, avoiding the infusion of blood products, and pulling out central venous catheter timely. As a normal flora in oral cavity, candida albicans enter into the lung through trachea cannula with oral secretion, form colonization, gradually intrude into the lower respiratory tract and then cause systemic infection. The main pathogens of severe entilator-associated pneumonia are pseudomonas aeruginosa and candida albicans. Therefore, it is important to standardize tracheal intubation, shorten mechanical ventilation time. On one hand, the application of broad-spectrum antibiotics damages the balance of normal flora in the body. Cotten Compared with the application of narrow-spectrum antibiotics, empirical application of broad-spectrum antibiotics cannot reduce the morbidity and mortality of nosocomial bacterial infection. By contrast, it will cause disastrous multiple drug-resistant bacteria infections and secondary IFIs. Therefore, for the application of broad-spectrum antibiotics, treatment drugs need to be taken seriously and the prophylaxis should be taken as little as possible.
In addition, the result of the prevention application fluconazole in a single factor χ2 test analysis shows that the morbidity of prophylaxis group is 4.087 times higher than the control group. But when listed as the Logistic regression analysis of many factors, the result shows the prophylaxis has no obvious effect on the incidence of disease. The reason for the result may be that the prophylaxis used in our center is selective. Patients in the fluconazole prophylaxis group are more severe with birth weight less than 1500g, more than 2 weeks using of broad-spectrum antibiotics and who need PICC or assisted ventilation. All these factors may increase the IFIs bur not the occurrence of IFIs caused by the application of fluconazole prevention. Therefore, when other exposure interference factors are excluded in the multi-factor analysis, preventive application of fluconazole is not the independent risk factor of IFIs.
In conclusion, the reduction of invasive manipulation, mechanical ventilation and center venipuncture time is emphasized for the prevention of IFIs of premature infants. At the same time, the application indication of antibiotics should be controlled and the broad-spectrum antibiotics application should be reduced.
The study also has shortcomings. First, the sample population consists of premature infants from a certain period of time in one center. It needs to be conducted in multiple centers and with the dynamic monitoring. Second, the prognosis analysis of premature infants with IFIs is limited to disease mortality and length of stay. Long-term outcome such as neurology, viscera function damage and complication are necessary to follow-up in the further.
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